EN
HI
Summary
As of 10 Oct, 2026, Astrazeneca Pharma India stock price is ₹5837. During the trading session, the stock has moved between an intraday low of ₹5640.00 and an intraday high of ₹5875.50. Over the last 52 weeks, Astrazeneca Pharma India has traded between ₹5640.00 and ₹9849.50.
The stock has recorded a trading volume of 8,979 shares,. Its Average Traded Price (ATP) is ₹5807.04, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹5837.00.
Astrazeneca Pharma India has an upper circuit limit of ₹7004.00 and a lower circuit limit of ₹4670.00. The total value traded stands at ₹5.21 CR, and the delivery percentage for the day is 51.93%.
The stock is currently traded with a market lot size of 1. Astrazeneca Pharma India also offers a dividend yield of 0%.
Astrazeneca Pharma India Share Price Chart
Astrazeneca Pharma India Share Key Metrics
Volume
8979.00
Market Cap
14592.50 CR
LTQ@LTP
3@5837.00
ATP
5807.04
Var Margin
14.72 %
Circuit Range
4670-7004
Delivery %
51.93 %
Value
5.21 CR
ASM/GSM
No
Market Lot
1
Astrazeneca Pharma India Resistance and Support
Pivot 5781.67
Resistance
First Resistance
5888.34
Second Resistance
6057.17
Third Resistance
6163.84
Support
First Support
5612.84
Second Support
5506.17
Third Support
5337.34
Astrazeneca Pharma India Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 5720 | 5837 | 2.05% | 5875.5 | 5640 |
| Thu Oct 08 2026 | 5950.5 | 5719.5 | -3.35% | 5950.5 | 5675 |
| Wed Oct 07 2026 | 6000.5 | 5918 | -1.05% | 6000.5 | 5802 |
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Rubicon Research Ltd.
1548.50
13.10 (0.85%)
Acutaas Chemicals Ltd.
3160.60
103.90 (3.40%)
Granules India Ltd.
815.25
0.20 (0.02%)
Shilpa Medicare Ltd.
1021.70
-3.60 (0.35%)
Caplin Point Laboratories Ltd.
2460.80
-88.00 (3.45%)
Molbio Diagnostics Ltd.
1438.60
-40.60 (2.74%)
Onesource Specialty Pharma Ltd.
1461.30
-16.90 (1.14%)
Pfizer Ltd.
3808.20
58.20 (1.55%)
Cohance Lifesciences Ltd.
441.00
-1.40 (0.32%)
Alembic Pharmaceuticals Ltd.
800.95
0.45 (0.06%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 5837 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 41.33 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 14592.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 9849.50 & 5640.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASTRAZEN
